Select Medical Corporati... (SEM)
NYSE: SEM
· Real-Time Price · USD
13.09
0.08 (0.61%)
At close: Sep 05, 2025, 3:59 PM
13.25
1.22%
After-hours: Sep 05, 2025, 07:13 PM EDT
Select Medical Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service, Other Revenue | 131.72M | 133.2M | 126.27M | 127.71M | 127.99M | 129.6M | 126.87M | 122.19M | 122.89M | 119.69M | 119.72M | 117.53M | 114.55M | 111.17M | 113.21M | 109.07M | 101.98M | 97.46M | 357.54M | 346.54M | 307.32M | 373.56M | 103.91M | 349.27M | n/a |
| Service, Other Revenue Growth | -1.11% | +5.49% | -1.13% | -0.22% | -1.24% | +2.15% | +3.83% | -0.57% | +2.68% | -0.03% | +1.86% | +2.61% | +3.04% | -1.80% | +3.80% | +6.95% | +4.64% | -72.74% | +3.17% | +12.76% | -17.73% | +259.52% | -70.25% | n/a | n/a |
| Health Care, Patient Service, Medicare Revenue | 381.56M | 390.31M | 374.17M | 356.42M | 362.5M | 398.75M | 369.93M | 362.57M | 368.09M | 385.48M | 367.58M | 353.54M | 363.34M | 364.09M | 344.33M | 352.95M | 350.65M | 371.04M | 1B | 958.74M | 833.33M | 929.31M | 365.99M | 936.03M | n/a |
| Health Care, Patient Service, Medicare Revenue Growth | -2.24% | +4.31% | +4.98% | -1.68% | -9.09% | +7.79% | +2.03% | -1.50% | -4.51% | +4.87% | +3.97% | -2.70% | -0.21% | +5.74% | -2.44% | +0.66% | -5.49% | -62.94% | +4.42% | +15.05% | -10.33% | +153.92% | -60.90% | n/a | n/a |
| Health Care, Patient Service, Non-Medicare Revenue | 826.3M | 829.67M | -623.03M | 1.28B | 1.27B | 1.26B | 1.16B | 1.18B | 1.18B | 1.16B | 1.09B | 1.1B | 1.11B | 1.12B | 1.1B | 1.07B | 1.11B | 1.08B | n/a | n/a | n/a | n/a | 904.69M | 108.04M | 64.5M |
| Health Care, Patient Service, Non-Medicare Revenue Growth | -0.41% | -233.17% | -148.78% | +0.62% | +0.69% | +8.47% | -1.60% | -0.22% | +2.05% | +6.00% | -0.23% | -0.92% | -1.55% | +2.00% | +2.80% | -3.53% | +3.10% | n/a | n/a | n/a | n/a | n/a | +737.38% | +67.49% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 35.66M | 33.01M | 80.2M | 47.35M | 49.7M | 48.45M | 44.09M | 41.32M | 42.51M | 42.28M | 38.76M | 39.49M | 37.27M | 37.51M | 37.95M | 37.88M | 35.74M | 35.4M | 35.23M | 35.52M | 33.46M | 33.83M | 34.06M | 34.38M | 31.34M | 28.68M | 30.32M | 29.98M | 29.19M | 31.78M | 30.63M | 27.07M | 28.27M | 28.07M | 25.7M | 27.09M | 25.87M | 28.27M | 24.14M | 22.2M | 24.04M | 21.68M |
| Selling, General, and Administrative Revenue Growth | +8.04% | -58.84% | +69.38% | -4.74% | +2.59% | +9.88% | +6.71% | -2.80% | +0.54% | +9.07% | -1.84% | +5.96% | -0.65% | -1.15% | +0.17% | +6.01% | +0.94% | +0.49% | -0.81% | +6.14% | -1.09% | -0.68% | -0.94% | +9.72% | +9.28% | -5.41% | +1.14% | +2.68% | -8.14% | +3.75% | +13.18% | -4.28% | +0.71% | +9.24% | -5.12% | +4.71% | -8.48% | +17.12% | +8.71% | -7.65% | +10.92% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |